133 related articles for article (PubMed ID: 26770464)
1. Tumor abnormal protein (TAP) examination contributes to primary diagnosis of bladder cancer.
Zhang L; Guo X; Min Y; Xu J
Int J Clin Exp Med; 2015; 8(10):18528-32. PubMed ID: 26770464
[TBL] [Abstract][Full Text] [Related]
2. [Expression of special AT-rich sequence-binding protein in bladder urothelial carcinoma and its clinical significance].
Liu CX; Wen Y; Xu K; Zheng SB; Xu YW; Chen BS
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1389-91, 1394. PubMed ID: 20584685
[TBL] [Abstract][Full Text] [Related]
3. [Retrospective study of young bladder urothelial carcinoma from a single center within 16 years].
Tang XG; Yan Y; Qiu M; Lu J; Lu M; Hou XF; Huang Y; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):630-633. PubMed ID: 30122762
[TBL] [Abstract][Full Text] [Related]
4. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
[TBL] [Abstract][Full Text] [Related]
5. [Value of fluorescence in situ hybridization of urine exfoliative cells in diagnosis of urinary bladder neoplasms].
Chen N; Gong J; Zeng H; Wei Q; Zhu YC; Chen M; Zhou Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):109-13. PubMed ID: 21355314
[TBL] [Abstract][Full Text] [Related]
6. Tumor Abnormal Protein as a Novel Biomarker in Papillary Thyroid Carcinoma.
Liu Z; Cai J; Yu Y; Fang H; Si Y; Jankee JJ; Shen M
Clin Lab; 2017 Mar; 63(3):479-485. PubMed ID: 28271680
[TBL] [Abstract][Full Text] [Related]
7. Prospective external validation of a bladder cancer detection model.
Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
[TBL] [Abstract][Full Text] [Related]
8. Bladder cancer in Sri Lanka: experience from a tertiary referral center.
Goonewardena SA; De Silva WA; De Silva MV
Int J Urol; 2004 Nov; 11(11):969-72. PubMed ID: 15509199
[TBL] [Abstract][Full Text] [Related]
9. [Quantitative analysis of telomerase activity in exfoliated urothelial cells for the diagnosis of bladder carcinoma].
Yokota K; Kanayama H; Kagawa S; Abe-Hashimoto J; Hirose M; Yoshimura T
Nihon Rinsho; 1998 May; 56(5):1292-8. PubMed ID: 9613140
[TBL] [Abstract][Full Text] [Related]
10. [DISSEMINATED CARCINOMATOSIS OF THE BONE MARROW WITH UROTHELIAL CARCINOMA].
Kohno M; Miyama K; Gohbara A; Onuki T; Sugiura S; Ikeda I
Nihon Hinyokika Gakkai Zasshi; 2015 Apr; 106(2):114-7. PubMed ID: 26415362
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary manifestations of urothelial carcinoma of the bladder.
Agrawal A; Sahni S; Vulisha AK; Gumpeni R; Shah R; Talwar A
Respir Med; 2017 Jul; 128():65-69. PubMed ID: 28610671
[TBL] [Abstract][Full Text] [Related]
12. [Urothelial carcinoma clear cell variant of the urinary bladder : a case report].
Isono M; Asano T; Shirotake S; Tasaki S; Asakuma J; Satoh M; Kimura F; Dai Y; Aida S
Hinyokika Kiyo; 2010 Mar; 56(3):163-5. PubMed ID: 20372045
[TBL] [Abstract][Full Text] [Related]
13. Paraganglioma of the urinary bladder: a lesion that may be misdiagnosed as urothelial carcinoma in transurethral resection specimens.
Zhou M; Epstein JI; Young RH
Am J Surg Pathol; 2004 Jan; 28(1):94-100. PubMed ID: 14707870
[TBL] [Abstract][Full Text] [Related]
14. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.
Leach FS; Hsieh JT; Molberg K; Saboorian MH; McConnell JD; Sagalowsky AI
Cancer; 2000 May; 88(10):2333-41. PubMed ID: 10820356
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of NMP22 and urinary cytology in patients with hematuria or a history of urothelial carcinoma.
Lee MY; Tsou MH; Cheng MH; Chang DS; Yang AL; Ko JS
World J Urol; 2000 Dec; 18(6):401-5. PubMed ID: 11204258
[TBL] [Abstract][Full Text] [Related]
16. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
[TBL] [Abstract][Full Text] [Related]
17. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.
Guo RQ; Xiong GY; Yang KW; Zhang L; He SM; Gong YQ; He Q; Li XY; Wang ZC; Bao ZQ; Li XS; Zhang K; Zhou LQ
Urol Oncol; 2018 Jul; 36(7):342.e15-342.e23. PubMed ID: 29706459
[TBL] [Abstract][Full Text] [Related]
18. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
[TBL] [Abstract][Full Text] [Related]
19. [Surgical treatment of metastatic urothelial carcinoma of the bladder: Review of the Cancer Committee of the French Association of Urology].
Neuzillet Y; Larré S; Comperat E; Rouprêt M; Pignot G; Houede N; Quintens H; Wallerand H; Roy C; Soulie M; Pfister C;
Prog Urol; 2013 Oct; 23(12):951-7. PubMed ID: 24090779
[TBL] [Abstract][Full Text] [Related]
20. [Large nested variant of urothelial carcinoma of urinary bladder: a clinicopathological analysis of five cases].
Yin XN; Zhang Q; He XL; Zhao M
Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):317-323. PubMed ID: 32268667
[No Abstract] [Full Text] [Related]
[Next] [New Search]
